Brookwood Investment Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Brookwood Investment Group’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.21K	Buy	+100	New	+$3.19K	﹤0.01%	536

Other funds holding ARKG

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

NAM

NTV Asset Management Charleston, West Virginia $1.02B AUM 31.16% 1-Year Est. Return

MFPI

Midwest Financial Partners Investments St. Cloud, Minnesota $241M AUM

CIC

Canal Insurance Company Greenville, South Carolina $456M AUM 40.11% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

CFIM

Client First Investment Management West Bend, Wisconsin $237M AUM 90.26% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

MWM

Moran Wealth Management Naples, Florida $3.67B AUM 36.71% 1-Year Est. Return

Brookwood Investment Group's ARKG Position: Q2 2026 in Review

Brookwood Investment Group opened a new position in ARK Genomic Revolution ETF (ARKG) in Q2 2026: 100 shares worth $4.21K. The stake represents ﹤0.01% of the portfolio and ranks #536 among its holdings.

145 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Brookwood Investment Group held 100 shares of ARK Genomic Revolution ETF worth $4.21K as of Q2 2026.
ARK Genomic Revolution ETF was a new Brookwood Investment Group position in Q2 2026.
ARK Genomic Revolution ETF made up ﹤0.01% of Brookwood Investment Group's portfolio in Q2 2026, its #536 holding.
145 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Brookwood Investment Group's 13F filing for Q2 2026, filed 23 Jul 2026.